Post hoc analysis of two Japanese RCTs in 403 children aged 5-16 with house dust mite allergic rhinitis: 300 IR SLIT-tablet reduced symptom score vs placebo by an estimated 13.1% overall and 27.3% in the highest disease-activity tertile.
Secondary analysisn = 403
Devillier et al. Allergic rhinitis activity and efficacy of 300 IR house dust mite sublingual immunotherapy tablet in pediatrics